Levora
Product Images NDC 53002-1565

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levora (NDC 53002-1565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021565)

Label for Levora 0.15/0.03 mg tablets, a 28-day oral contraceptive regimen by RPK Pharmaceuticals, Inc. The label indicates a package containing 28 tablets with instructions to take one tablet daily as directed. It includes fields for patient and prescriber information, lot number, expiration date, and barcode.*

FDA Label Image

Chemical Structure (Levora 01)

Chemical structure of Levora, an oral contraceptive product by RPK Pharmaceuticals, Inc. The structure shows a steroid backbone with several hydroxyl, methyl, and ketone functional groups.*

FDA Label Image

Chemical Structure (Levora 02)

Chemical structure of the active ingredient shown on the Levora product image by RPK Pharmaceuticals, Inc. It depicts the molecular arrangement including hydroxyl groups and methyl groups characteristic of a steroidal compound.*

FDA Label Image

Table Ii (Levora 03)

A horizontal bar chart depicting the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC users (range 1-5), COC-Users (range 3-9), Pregnancy (range 5-20), and Postpartum (12 weeks only) with the highest range from 40 to 65. The chart includes a note on pregnancy data based on actual pregnancy duration and a model assumption of nine months duration with rates of 7 to 27 per 10,000 WY.*

FDA Label Image

Blister Pack (Levora 04)

An illustration showing a vertical scale indicating pregnancy rates per 100 women in one year, ranging from fewer than 1 to 85 or more pregnancies. Next to the scale are grouped contraceptive methods ranked by pregnancy frequency, from most effective (implants, injections, intrauterine devices, sterilization) to least effective (no birth control). Intermediate categories list birth control pills, skin patch, vaginal rings with hormones; condoms and diaphragm; and behavioral methods like abstinence during fertile days, spermicide, and withdrawal.*

FDA Label Image

Levora 04a

Levora 0.15/30 oral contraceptive blister pack label showing a 28-day cycle with circular pill compartments arranged in four rows of seven. The label indicates active tablets contain levonorgestrel 0.15 mg and ethinyl estradiol 0.03 mg, with noted inactive tablets in the fourth week. Directions include following arrows for daily dosing from Sunday to Saturday.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.